VisionPoint Advisory Group’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$249K Sell
12,615
-11,970
-49% -$300K 0.04% 391
2026
Q2
$703K Sell
24,585
-64,678
-72% -$2.05M 0.11% 199
2026
Q1
$2.81M Sell
89,263
-12,200
-12% -$384K 0.53% 44
2025
Q4
$2.99M Buy
101,463
+26,706
+36% +$742K 0.58% 44
2025
Q3
$1.89M Sell
74,757
-2,611
-3% -$63.6K 0.38% 73
2025
Q2
$1.86M Sell
77,368
-5,745
-7% -$133K 0.4% 68
2025
Q1
$1.9M Buy
83,113
+6,750
+9% +$163K 0.65% 46
2024
Q4
$1.92M Buy
76,363
+7,205
+10% +$183K 0.66% 47
2024
Q3
$1.72M Buy
+69,158
New +$2.05M 0.58% 45

Other funds holding RTO

VisionPoint Advisory Group's RTO Position: Q3 2026 in Review

VisionPoint Advisory Group reduced its Rentokil (RTO) stake by 49% in Q3 2026, selling an estimated $300K and leaving 12,615 shares worth $249K. The position accounts for 0.04% of the portfolio, ranked #391.

VisionPoint Advisory Group first reported a position in RTO in Q3 2024 and has held it in 9 quarters since. The position peaked at $2.99M in Q4 2025. 26 funds tracked by Wall St. Rank hold RTO as of Q3 2026.

  • VisionPoint Advisory Group held 12,615 shares of Rentokil worth $249K as of Q3 2026.
  • VisionPoint Advisory Group sold 11,970 Rentokil shares in Q3 2026, an estimated $300K.
  • Rentokil made up 0.04% of VisionPoint Advisory Group's portfolio in Q3 2026, its #391 holding.
  • VisionPoint Advisory Group first reported a position in Rentokil in Q3 2024 and has held it in 9 quarters since.
  • VisionPoint Advisory Group's Rentokil position peaked at $2.99M in Q4 2025.
  • 26 funds tracked by Wall St. Rank held Rentokil as of Q3 2026.

Based on VisionPoint Advisory Group's 13F filing for Q3 2026, filed 9 Oct 2026.